NeuroSCS: Spinal Cord Stimulation Assisted by Motor Rehabilitation Training for Restoring Motor Function After Spinal Cord Injury

Sponsor
IRCCS San Raffaele (Other)
Overall Status
Recruiting
CT.gov ID
NCT05926843
Collaborator
Scuola Superiore Sant'Anna di Pisa (Other)
10
1
1
36.4
0.3

Study Details

Study Description

Brief Summary

Interventional prospective longitudinal on the evaluation of spinal cord stimulation (SCS) assisted by motor rehabilitation training for restoring motor function in patients with spinal cord injury (SCI). The investigators will enroll ten research participants with clinically incomplete/complete SCI (patients with paraplegia or severe paraparesis) who will undergo SCS subsequently assisted by motor rehabilitation training for restoring motor function at IRCCS Ospedale San Raffaele, Milan, Italy. The main goal of the project is to evaluate the improvement in motor function generated by the combination of SCS and locomotor training. In line with recently published studies, the investigators propose that daily locomotor training in the presence of SCS with continuous stimulation parameters setting will enable the SCI individuals to stand and step independently while bearing full weight.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Spinal cord stimulation surgery (device) and motor rehabilitation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of Spinal Cord Stimulation Assisted by Motor Rehabilitation Training for Restoring Motor Function After Spinal Cord Injury: an Interventional, Prospective, Monocentric Study
Actual Study Start Date :
Apr 19, 2023
Anticipated Primary Completion Date :
May 1, 2025
Anticipated Study Completion Date :
May 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Individuals with functionally complete/incomplete spinal cord injury

Individuals with functionally complete/incomplete spinal cord injury (ASIA grade A, B or C) who will undergo SCS for chronic pain

Procedure: Spinal cord stimulation surgery (device) and motor rehabilitation
The first part of the study will involve a preoperative evaluation. Participants' clinical history, neurological, neurophysiological and advanced brain/spine MRI examination will be assessed (Part 1). Subsequently, participants will undergo spinal cord stimulation surgery which involves the implantation of a medical device (Part 2). After the surgery, the research participants will be hospitalized at the Neurosurgery Unit (10 days) to monitor the incision site (Part 3). Thereafter, the patients will be moved (for at least 6 weeks) to the Rehabilitation Unit in order to identify appropriate stimulation parameters for inducing stepping and standing and for starting training. The combination of epidural stimulation with manual step/stand training will be thus evaluated (Part 4). Patients will be finally assessed by clinical evaluation, advanced MRI and neurophysiological examination to study the brain, spine and peripheral functions after six months (Part 5).

Outcome Measures

Primary Outcome Measures

  1. Motor changes (MRC) [Before surgery, then monthly up to 6-month from surgery]

    The Medical Research Council's (MRC) scale of muscle power will be used to evaluate motor weakness. The MRC scale of muscle strength uses a score from Grade 5 (normal) to Grade 0 (no visible contraction) to assess the power of a particular muscle group in relation to the movement of a single joint.

  2. Motor changes (LEFS)) [Before surgery, then monthly up to 6-month from surgery]

    The Lower Extremity Functional Scale (LEFS) will be used by clinicians as a measure of lower extremity function. It is a questionnaire containing 20 questions about a person's ability to perform everyday tasks (minimum score 0, maximum score 80).

Secondary Outcome Measures

  1. Spasticity changes [Before surgery, then monthly up to 6-month from surgery]

    The Modified Ashworth scale will be used to evaluate spasticity. This scale grades the muscle tone from 0 (normal) to 4 (severe spasticity).

  2. Longitudinal neurophysiological reorganization (electromyography) [Before surgery and 6 months after procedure]

    Electromyography will be used to evaluate muscle response or electrical activity in response to a nerve's stimulation.

  3. Longitudinal neurophysiological reorganization (motor evoked potentials) [Before surgery and 6 months after procedure]

    Motor evoked potentials will be used to evaluate electrical signals recorded from the descending motor pathways or from muscles following stimulation of motor pathways within the brain.

  4. Longitudinal neurophysiological reorganization (sensory evoked potentials) [Before surgery and 6 months after procedure]

    Sensory evoked potentials will be used to assess electrical activity in the brain in response to sensory stimulation.

  5. Longitudinal brain and spine MRI reorganization [Before surgery and 6 months after procedure]

    Structural and functional brain and spine MRI analysis.

  6. Chronic pain changes (MPQ) [Before surgery and 6 months after procedure]

    The McGill Pain Questionnaire (MPQ) can be used to evaluate a person experiencing significant pain. It consists of 15 descriptors (11 sensory; 4 affective) which are rated on an intensity scale as 0 = none, 1 = mild, 2 = moderate or 3 = severe.

  7. Chronic pain changes (PCS) [Before surgery and 6 months after procedure]

    The Pain Catastrophizing Scale (PCS) assesses the extent of catastrophic thinking. It assesses the extent of catastrophic thinking due to low back pain according to 3 components: rumination, magnification, and helplessness. It is a 13-item scale, with a total range of 0 to 52. Higher scores are associated with higher amounts of pain catastrophizing.

  8. Chronic pain changes (ASC-12) [Before surgery and 6 months after procedure]

    12-item Allodynia Symptom Checklist (ASC-12) evaluates presence of allodynia and hypoesthesia.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of SCI from at least one-year post injury;

  • Complete or incomplete spinal cord damage (ASIA grade A, B or C) conditioning chronic neuropathic pain and motor impairment

  • Age > 18 years;

  • Indication to spinal cord stimulation surgery for chronic pain;

  • Be unable to stand or step independently;

  • No current anti-spasticity medication regimen;

  • No botox injections in the prior 3 months;

  • Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study;

  • Willingness and ability to comply with scheduled visits and other trial procedures.

Exclusion Criteria:
  • Any person unable to lie still within the environment of the MRI scanner for the required period to perform the study and those where MRI scanning is contraindicated (i.e. metal clips, claustrophobia);

  • Pregnancy or breastfeeding;

  • Any significant psychiatric disease;

  • Use of illicit drugs;

  • Unstable medical condition without cardiopulmonary disease or dysautonomia that would contraindicate standing or stepping;

  • Painful musculoskeletal dysfunction, unhealed fracture, contracture, pressure sore, or urinary tract infection that might interfere with stand or step training;

Contacts and Locations

Locations

Site City State Country Postal Code
1 IRCCS Ospedale San Raffaele Milan Italy 20132

Sponsors and Collaborators

  • IRCCS San Raffaele
  • Scuola Superiore Sant'Anna di Pisa

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Albano Luigi, MD, PhD, Assistant Professor of Neurosurgery, IRCCS San Raffaele
ClinicalTrials.gov Identifier:
NCT05926843
Other Study ID Numbers:
  • Neuro-SCS-001
First Posted:
Jul 3, 2023
Last Update Posted:
Jul 3, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Albano Luigi, MD, PhD, Assistant Professor of Neurosurgery, IRCCS San Raffaele
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 3, 2023